Vanguard Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
|
|||||
|
2025
Q1 | $16.5M | Sell |
|
|||||
|
2024
Q4 | $25.8M | Sell |
|
|||||
|
2024
Q3 | $21.5M | Buy |
|
|||||
|
2024
Q2 | $24M | Buy |
|
|||||
|
2024
Q1 | $23.7M | Buy |
|
|||||
|
2023
Q4 | $15.4M | Buy |
|
|||||
|
2023
Q3 | $4.65M | Buy |
|
|||||
|
2023
Q2 | $5.93M | Sell |
|
|||||
|
2023
Q1 | $6.87M | Buy |
|
|||||
|
2022
Q4 | $26.5M | Buy |
|
|||||
|
2022
Q3 | $27.1M | Sell |
|
|||||
|
2022
Q2 | $27.3M | Sell |
|
|||||
|
2022
Q1 | $20.8M | Buy |
|
|||||
|
2021
Q4 | $18.8M | Buy |
|
|||||
|
2021
Q3 | $22.2M | Sell |
|
|||||
|
2021
Q2 | $48.6M | Sell |
|
|||||
|
2021
Q1 | $65.1M | Sell |
|
|||||
|
2020
Q4 | $61.5M | Buy |
|
|||||
|
2020
Q3 | $85.7M | Sell |
|
|||||
|
2020
Q2 | $121M | Sell |
|
|||||
|
2020
Q1 | $78.2M | Sell |
|
|||||
|
2019
Q4 | $158M | Sell |
|
|||||
|
2019
Q3 | $97.8M | Buy |
|
|||||
|
2019
Q2 | $105M | Buy |
|
|||||
|
2019
Q1 | $70.6M | Buy |
|
|||||
|
2018
Q4 | $78.1M | Buy |
|
|||||
|
2018
Q3 | $73.2M | Buy |
|
|||||
|
2018
Q2 | $60.7M | Buy |
|
|||||
|
2018
Q1 | $107M | Buy |
|
|||||
|
2017
Q4 | $61.3M | Buy |
|
|||||
|
2017
Q3 | $44.1M | Buy |
|
|||||
|
2017
Q2 | $35M | Buy |
|
|||||
|
2017
Q1 | $25.6M | Buy |
|
|||||
|
2016
Q4 | $7.52M | Buy |
|
|||||
|
2016
Q3 | $7.87M | Sell |
|
|||||
|
2016
Q2 | $8.02M | Buy |
|
|||||
|
2016
Q1 | $12.5M | Buy |
|
|||||
|
2015
Q4 | $16.2M | Sell |
|
|||||
|
2015
Q3 | $17.2M | Buy |
|
|||||
|
2015
Q2 | $57.9M | Buy |
|
|||||
|
2015
Q1 | $36.7M | Buy |
|
|||||
|
2014
Q4 | $10.1M | Buy |
|
|||||
|
2014
Q3 | $3.9M | Buy |
|
|||||
|
2014
Q2 | $2.52M | Buy |
|
|||||
|
2014
Q1 | $2.4M | Buy |
|
|||||
|
2013
Q4 | $1.88M | Buy |
|
|||||
|
2013
Q3 | $1.39M | Buy |
|